etherna, a biotech company specialising in mRNA and lipid nanoparticle [...]

Almirall delivered net sales growth of 12.4% in 2025, surpassing [...]

Almirall has received regulatory approval in China for its oral [...]

Almirall has announced plans to initiate a phase 3 clinical [...]

Almirall has hosted the fourth edition of ImmunoSkin, its annual [...]

Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

Almirall has presented new two-year results from its POSITIVE study [...]